Conversion to monotherapy maintenance immunosuppression in pediatric renal transplant recipients: A single center experience

Pediatric Transplantation

Volumn 15, Issue 1, 2011, Pages 119-120

  Sinha, R ^a   Tse, Y ^a   Marks, S D ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; CHILDHOOD DISEASE; CHRONIC ALLOGRAFT NEPHROPATHY; DRUG MEGADOSE; GRAFT RECIPIENT; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LETTER; MONOTHERAPY; TREATMENT OUTCOME; VIREMIA;

ADOLESCENT; ADRENAL CORTEX HORMONES; CALCINEURIN; CHILD; FEMALE; GLOMERULAR FILTRATION RATE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PEDIATRICS; RENAL INSUFFICIENCY; TIME FACTORS; TREATMENT OUTCOME;

EID: 78751676301     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01427.x     Document Type: Letter

References (6)

1. Akalin E,. Immunosuppression minimization protocols: How should they be monitored? Nat Clin Pract Nephrol 2008: 4: 484-485.
2. Tan HP, Donaldson J, Ellis D, et al. Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. Transplantation 2008: 86: 1725-1731.
3. Touchard G, Hauet T, Cogny Van Weydevelt F, et al. Maintenance cyclosporin monotherapy after renal transplantation - clinical predictors of long-term outcome. Nephrol Dial Transplant 1997: 12: 1956-1960.
4. Bäckman L, Aselius H, Lindberger K, et al. Steroid-free immunosuppression in kidney transplant recipients and prograf monotherapy: An interim analysis of a prospective multicenter trial. Transplant Proc 2006: 38: 2654-2656.
5. Land W, Schneeberger H, Weiss M, et al. Mycophenolate mofetil monotherapy: An optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients. Transplant Proc 2001: 33: 29S.
6. Shapiro R, Zeevi A, Basu A, et al. Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation 2008: 85: 1125-1132.